Legend Biotech (LEGN) Receivables - Other (2019 - 2024)
Legend Biotech (LEGN) posted Receivables - Other of $780000.0 for Q4 2024, down 1.27% on a QoQ basis from $790000.0 in Q4 2023, and down 1.27% year-over-year from $790000.0 in Q1 2024.
Legend Biotech (LEGN) has 6 years of Receivables - Other data on file, last reported at $780000.0 in Q4 2024.
- In Q4 2024, Receivables - Other fell 1.27% year-over-year to $780000.0; the TTM figure through Dec 2024 stood at $780000.0 (down 1.27% YoY), while the FY2024 annual figure was $780000.0, down 1.27% from the prior year.
- Receivables - Other slipped to $780000.0 in Q4 2024, from $790000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $948000.0 in Q4 2022 and bottomed at $20000.0 in Q4 2020.
- A 5-year average of $677166.7 and a median of $785000.0 in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2020 — Receivables - Other sank 78.49% — and 2021, when it surged 4085.0%.
- Year by year, Receivables - Other stood at $20000.0 in 2020, then surged by 4085.0% to $837000.0 in 2021, then increased by 13.26% to $948000.0 in 2022, then retreated by 16.67% to $790000.0 in 2023, then decreased by 1.27% to $780000.0 in 2024.
- The last three Receivables - Other figures came in at $780000.0 (Q4 2024), $790000.0 (Q4 2023), and $948000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Dec 31, 2022 | 948,000.00 |
| Dec 31, 2022 | 948,000.00 |
| Mar 31, 2022 | 688,000.00 |
| Mar 31, 2022 | 688,000.00 |
| Dec 31, 2021 | 837,000.00 |
| Dec 31, 2021 | 837,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Dec 31, 2019 | 1.04 Mn |
| Dec 31, 2019 | 1.04 Mn |